ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,389Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 198

$811K Total Retail Price of All Prescriptions

Rank: 20 out of 198

624 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,297 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 566 453 1 1
LISINOPRIL 438 344 2 6
FUROSEMIDE 425 320 3 5
HYDROCODONE-ACETAMINOPHEN 419 208 S3 4 8
SIMVASTATIN 417 356 5 2
OMEPRAZOLE 367 266 6 3
WARFARIN SODIUM 329 325 7 7
GABAPENTIN 269 133 8 14
AMLODIPINE BESYLATE 230 183 9 4
METFORMIN HCL 221 143 10 13
POTASSIUM CHLORIDE 217 171 11 9
METOPROLOL SUCCINATE 206 182 12 11
TRAMADOL HCL 197 108 13 15
PRAVASTATIN SODIUM 177 128 14 19
ATENOLOL 167 130 15 17
ZOLPIDEM TARTRATE 155 103 16 22
METOPROLOL TARTRATE 153 122 17 10
LOSARTAN POTASSIUM 152 139 18 18
ATORVASTATIN CALCIUM 151 119 19 12
CRESTOR 147 112 20 26
CARVEDILOL 134 115 21 24
HYDROCHLOROTHIAZIDE 133 114 22 16
POLYETHYLENE GLYCOL 3350 121 96 23 41
SPIRONOLACTONE 120 104 24 37
CITALOPRAM HBR 118 102 25 20
CYMBALTA 118 60 25 48
FLUOXETINE HCL 107 66 27 78
TRAZODONE HCL 99 13 28 50
DONEPEZIL HCL 98 88 29 28
DIGOXIN 93 93 30 43
CELEBREX 91 79 31 59
ALLOPURINOL 90 73 32 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 52 33 38
CYCLOBENZAPRINE HCL 85 32 R 34 67
MELOXICAM 84 66 35 30
MIRTAZAPINE 82 71 36 44
AZITHROMYCIN 77 51 37 56
RANITIDINE HCL 74 30 38 54
PANTOPRAZOLE SODIUM 73 56 39 31
ABILIFY 73 26 39 177
LOSARTAN-HYDROCHLOROTHIAZIDE 73 69 39 49
GLIPIZIDE ER 72 35 42 83
PAROXETINE HCL 72 59 42 65
DIOVAN 72 58 42 34
CLOPIDOGREL 68 54 45 42
PREDNISONE 68 51 45 29
SERTRALINE HCL 67 43 47 25
IBUPROFEN 67 33 47 124
TAMSULOSIN HCL 67 56 47 27
OXYBUTYNIN CHLORIDE 66 42 50 89
TRIAMTERENE-HCTZ 65 40 51 32
ISOSORBIDE MONONITRATE ER 64 63 52 60
SYNTHROID 64 35 52 36
LANTUS SOLOSTAR 61 49 54 85
MORPHINE SULFATE ER 60 23 S2 55 160
FLUCONAZOLE 60 33 55 193
PREMARIN 60 22 R 55 101
FLUTICASONE PROPIONATE 59 57 58 39
ROPINIROLE HCL 59 24 58 74
ESCITALOPRAM OXALATE 59 18 58 53
ALENDRONATE SODIUM 59 59 58 21
ENALAPRIL MALEATE 58 48 62 51
QUETIAPINE FUMARATE 56 45 63 76
PLAVIX 55 44 64 66
VERAPAMIL ER 53 52 65 117
ADVAIR DISKUS 51 36 66 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.